NCT05240885 Metabolic and Functional Consequences of Aging in Health and Disease
| NCT ID | NCT05240885 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Texas A&M University |
| Condition | Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-03-04 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-03-04 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Considerable heterogeneity in the aging population has been observed. The exceptional longevity of individuals reaching 100 years old, so-called centenarians may be an example of life-long healthy aging, or added years may be spent in poor health with decreased physical and cognitive functioning. Current knowledge of the aging experience and the trajectories of physical and cognitive decline across various age groups are not well-understood, yet crucial to prevent spending added years in disease. Hence, the study objective is to develop the metabolic profile associated with aging-related disorders measured as the incidence of impaired functional capacity, cognitive function, and/or well-being.
Eligibility Criteria
Inclusion Criteria: * Stable body-weight (± 5%) for the past 3 months * Subject is judged to be in satisfactory health based on medical history, physical examination, and laboratory screening evaluations. * Ability to walk, sit down and stand up independently or with walking mobility aids * Ability to lie in a supine or elevated position for up to 3 hours * Willingness and ability to comply with the protocol Exclusion Criteria: * Insulin dependent diabetes mellitus * Established diagnosis of malignancy * History of untreated metabolic diseases including hepatic or renal disorder * Presence of acute illness or metabolically unstable chronic illness * Presence of fever within the last 3 days * Use of short course of oral corticosteroids within 4 weeks preceding study day * Failure to give informed consent or Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements * (Possible) pregnancy * Already enrolled in another clinical trial and that clinical trial interferes with participating in this study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05240885 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05240885 currently recruiting?
Yes, NCT05240885 is actively recruiting participants. Contact the research team at le.ruebush@ctral.org for enrollment information.
Where is the NCT05240885 trial being conducted?
This trial is being conducted at College Station, United States.
Who is sponsoring the NCT05240885 clinical trial?
NCT05240885 is sponsored by Texas A&M University. The trial plans to enroll 100 participants.